G1X-CGD
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for G1X-CGD, covering 2026-04-06 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: Part B- G1X-CGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous Disease [Phase 1, Phase 2]